Discovery of a novel rhein-SAHA hybrid as a multi-targeted anti-glioblastoma drug
- 19 Downloads
Glioblastoma multiforme (GBM) is the most common malignant tumor of the central nervous system (CNS). Effective treatments remain limited. Therefore, novel chemotherapy drugs with high efficiency and few adverse effects are urgently needed. Histone deacetylase (HDAC) and serum and glucocorticoid-regulated protein kinase 1 (SGK1) are targets for the prevention and treatment of GBM. Rhein has antitumor and SGK1 suppression effects, although its biological activity is limited by poor bioavailability. To improve the drug-like properties of rhein, we constructed a novel rhein-hydroxyethyl hydroxamic acid derivative (SYSUP007), which combined rhein with the HDAC inhibitor, suberoylanilide hydroxamic acid (SAHA). In the present study, the human GBM cell lines, T98G, U87 and U251, were used to investigate the anticancer effects of SYSUP007 in vitro. We found that SYSUP007 was more effective in inhibiting glioma cell proliferation, invasion and migration in vitro compared with the effects of rhein and SAHA. We also confirmed that SYSUP007 increased the expression of Ac-K100 and NDRG1 (targets of HDAC and SGK1). The present study indicates the potential that SYSUP007, as a novel rhein and SAHA derivative, for development as an anti-cancer therapy.
KeywordsRhein SAHA Glioblastoma Multi-targeted compound
This study was supported by grants to R. Pi from Guangdong Provincial International Cooperation Project of Science & Technology (No. 2013B051000038), The National Natural Science Foundation of China (No. 31371070 and 81671264) and the Fundamental Research Funds for the Central Universities (No. 15ykjc08b) and a grant to J. Chen from The National Natural Science Foundation of China (No. 81703539).
Compliance with ethical standards
Conflict of interest
All authors declare that they have no conflicts of interest.
This article does not contain any studies with human participants or animals performed by any of the authors.
For this type of study, formal consent is not required.
- 1.Ostrom QT, Gittleman H, Liao P, Rouse C, Chen Y, Dowling J, Wolinsky Y, Kruchko C, Barnholtz-Sloan J (2014) CBTRUS Statistical Report: Primary Brain and Central Nervous System Tumors Diagnosed in the United States in 2007–2011. Neuro-Oncology 16 (suppl 4):iv1–63Google Scholar
- 2.Li H, Chen L, Li JJ, Zhou Q, Huang AN, Liu WW, Wang K, Gao L, Qi ST, Lu YT (2018) miR-519a enhances chemosensitivity and promotes autophagy in glioblastoma by targeting STAT3/Bcl2 signaling pathway. J Hematol Oncol 11. https://doi.org/10.1186/s13045-018-0618-0
- 4.Alex T, Atique A, Kyung-Sub M, Lesniak MS (2013) The art of gene therapy for glioma: a review of the challenging road to the bedside. J Neurol Neurosurg Psychiatry 84(4):326–326Google Scholar
- 5.Kibble M, Saarinen N, Tang J, Wennerberg K, Mäkelä S, Aittokallio T (2015) Network pharmacology applications to map the unexplored target space and therapeutic potential of natural products. Nat Prod Rep 32(8):1249–1266Google Scholar
- 6.He M, Luo M, Liu Q, Chen J, Li K, Zheng M, Weng Y, Ouyang L, Liu A (2016) Combination treatment with fasudil and clioquinol produces synergistic anti-tumor effects in U87 glioblastoma cells by activating apoptosis and autophagy. J Neuro-Oncol 127:261–270Google Scholar
- 7.Falkenberg KJ, Johnstone RW (2014) Histone deacetylases and their inhibitors in cancer, neurological diseases and immune disorders. Nat Rev Drug Discov 13(9):673–691Google Scholar
- 9.Wang J, Yan WX, Li JT, Peng SB, Li J, Xiao HJ, Wen XQ (2016) Correlation between HDAC6 expression and clinical features of renal cell carcinoma. Int J Clin Exp Pathol 9(9):9364–9371Google Scholar
- 11.Moyal L, Goldfeiz N, Gorovitz B, Rephaeli A, Tal E, Tarasenko N, Nudelman A, Ziv Y, Hodak E (2018) AN-7, a butyric acid prodrug, sensitizes cutaneous T-cell lymphoma cell lines to doxorubicin via inhibition of DNA double strand breaks repair. Investig New Drugs 36(1):1–9. https://doi.org/10.1007/s10637-017-0500-x Google Scholar
- 12.Huang ZM, Peng SW, Knoff J, Lee SY, Yang B, Wu TC, Hung CF (2015) Combination of proteasome and HDAC inhibitor enhances HPV16 E7-specific CD8(+) T cell immune response and antitumor effects in a preclinical cervical cancer model. J Biomed Sci 22. https://doi.org/10.1186/s12929-014-0111-1
- 13.Pont LM, Naipal K, Kloezeman JJ, Venkatesan S, van den Bent M, van Gent DC, Dirven CM, Kanaar R, Lamfers ML, Leenstra S (2015) DNA damage response and anti-apoptotic proteins predict radiosensitization efficacy of HDAC inhibitors SAHA and LBH589 in patient-derived glioblastoma cells. Cancer Letters 356 (2 Pt B):525–535. https://doi.org/10.1016/j.canlet.2014.09.049
- 15.Wu L, Cao K, Ni Z, Wang S, Li W, Liu X, Chen Z (2018) Rhein reverses doxorubicin resistance in SMMC-7721 liver cancer cells by inhibiting energy metabolism and inducing mitochondrial permeability transition pore opening. BioFactors (Oxford, England):8. https://doi.org/10.1002/biof.1462
- 16.Zhang Q, Yin SS, Liu L, Liu ZH, Cao WS (2016) Rhein reversal of DNA hypermethylation-associated Klotho suppression ameliorates renal fibrosis in mice. Sci Rep:6. https://doi.org/10.1038/srep34597
- 19.Li QH, Wen J, Yu KT, Shu Y, He WL, Chu HX, Zhang B, Ge C (2018) Aloe-emodin induces apoptosis in human oral squamous cell carcinoma SCC15 cells. BMC Complement Altern Med 18. https://doi.org/10.1186/s12906-018-2353-z
- 21.Castel P, Ellis H, Bago R, Toska E, Razavi P, Carmona FJ, Kannan S, Verma CS, Dickler M, Chandarlapaty S, Brogi E, Alessi DR, Baselga J, Scaltriti M (2016) PDK1-SGK1 Signaling Sustains AKT-Independent mTORC1 Activation and Confers Resistance to PI3Kalpha Inhibition. Cancer Cell 30(2):229–242. https://doi.org/10.1016/j.ccell.2016.06.004 Google Scholar
- 22.Talarico C, Dattilo V, D'Antona L, Barone A, Amodio N, Belviso S, Musumeci F, Abbruzzese C, Bianco C, Trapasso F, Schenone S, Alcaro S, Ortuso F, Florio T, Paggi MG, Perrotti N, Amato R (2016) SI113, a SGK1 inhibitor, potentiates the effects of radiotherapy, modulates the response to oxidative stress and induces cytotoxic autophagy in human glioblastoma multiforme cells. Oncotarget 7 (13):15868–15884. https://doi.org/10.18632/oncotarget.7520
- 26.Yin XF, Zhang Q, Chen ZY, Wang HF, Li X, Wang HX, Li HX, Kang CM, Chu S, Li KF, Li Y, Qiu YR (2018) NLRP3 in human glioma is correlated with increased WHO grade, and regulates cellular proliferation, apoptosis and metastasis via epithelial-mesenchymal transition and the PTEN/AKT signaling pathway. Int J Oncol 53(3):973–986. https://doi.org/10.3892/ijo.2018.4480 Google Scholar
- 27.Orlacchio A, Ranieri M, Brave M, Arciuch VA, Forde T, De Martino D, Anderson KE, Hawkins P, Di Cristofano A (2017) SGK1 Is a Critical Component of an AKT-Independent Pathway Essential for PI3K-Mediated Tumor Development and Maintenance. Cancer Res 77(24):6914–6926. https://doi.org/10.1158/0008-5472.can-17-2105 Google Scholar
- 28.Marampon F, Leoni F, Mancini A, Pietrantoni I, Codenotti S, Letizia F, Megiorni F, Porro G, Galbiati E, Pozzi P, Mascagni P, Budillon A, Maggio R, Tombolini V, Fanzani A, Gravina GL, Festuccia C (2018) Histone deacetylase inhibitor ITF2357 (givinostat) reverts transformed phenotype and counteracts stemness in in vitro and in vivo models of human glioblastoma. J Cancer Research Clinical Oncology 1–17 https://doi.org/10.1007/s00432-018-2800-8
- 32.Weiler M, Blaes J, Pusch S, Sahm F, Czabanka M, Luger S, Bunse L, Solecki G, Eichwald V, Jugold M, Hodecker S, Osswald M, Meisner C, Hielscher T, Rubmann P, Pfenning PN, Ronellenfitsch M, Kempf T, Schnolzer M, Abdollahi A, Lang F, Bendszus M, von Deimling A, Winkler F, Weller M, Vajkoczy P, Platten M, Wick W (2014) mTOR target NDRG1 confers MGMT-dependent resistance to alkylating chemotherapy. Proc Natl Acad Sci U S A 111 (1):409–414. https://doi.org/10.1073/pnas.1314469111
- 33.Chen X, Chen Q, Yalin TU, Rongbiao PI (2016) New progress of serum and glucocorticoid-inducible kinase 1 on CNS diseases. J Pharm Res 35:559–569Google Scholar
- 35.Wang X, Wang F, Zhang X, Rheumatology DO (2013) Rhein attenuates renal fibrosis through reducing the expression of serum and glucocorticoid-induced protein kinase in diabetic rats. J Binzhou Medical University 36:253Google Scholar